Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
Clinical trial NCT02688556 · COMPLETED
Trial details
- NCT number
- NCT02688556
- Sponsor
- Sun Pharmaceutical Industries Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2016-11-01
- Enrollment
- 745
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.